Jeffrey Gudin
2020
In 2020, Jeffrey Gudin earned a total compensation of $173K as Executive VP, Chief Medical Officer at Virpax Pharmaceuticals.
Compensation breakdown
| Option Awards | $173,000 |
|---|---|
| Total | $173,000 |
Gudin received $173K in option awards, accounting for 100% of the total pay in 2020.
Rankings
In 2020, Jeffrey Gudin's compensation ranked 12,685th out of 13,090 executives tracked by ExecPay. In other words, Gudin earned more than 3.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,685 out of 13,090 | 3rd |
Division Manufacturing | 5,442 out of 5,624 | 3rd |
Major group Chemicals And Allied Products | 2,197 out of 2,257 | 3rd |
Industry group Drugs | 1,909 out of 1,957 | 3rd |
Industry Pharmaceutical Preparations | 1,423 out of 1,462 | 3rd |
Source: SEC filing on June 15, 2022.
Gudin's colleagues
We found two more compensation records of executives who worked with Jeffrey Gudin at Virpax Pharmaceuticals in 2020.